Xu Zheng-ping, Tsuji Takanori, Riordan James F, Hu Guo-fu
Center for Biochemical and Biophysical Sciences and Medicine, Harvard Medical School, One Kendall Square, Building 600, 3rd Floor, Cambridge, MA 02139, USA.
Biochem Biophys Res Commun. 2002 Jun 7;294(2):287-92. doi: 10.1016/S0006-291X(02)00479-5.
Angiogenin is a potent angiogenic protein whose inhibition is known to prevent human tumor growth in athymic mice. It is secreted by both tumor and normal cells; and interacts with endothelial and smooth muscle cells to induce a wide range of cellular responses including cell migration and invasion, proliferation, and formation of tubular structures. Angiogenin is rapidly endocytosed and translocated to the cell nucleus where it accumulates in the nucleolus and binds to DNA. Although nuclear translocation is necessary for its angiogenic activity, the nuclear function of angiogenin is unclear. Here we report that exogenous angiogenin enhances the production of 45S rRNA in endothelial cells, and reduction of endogenous angiogenin inhibits its transcription. In a nuclear run-on assay, angiogenin stimulates RNA synthesis including that containing the initiation site sequences of 45S rRNA. This suggests that the nuclear function of angiogenin relates to its capacity to induce rRNA synthesis. Because rRNA transcription is essential for the synthesis of new ribosomes that are necessary for protein translation and cell growth, inhibition of angiogenin-stimulated transcription of rRNA may inhibit angiogenesis and therefore, would serve as a molecular target for therapeutic intervention.
血管生成素是一种强效血管生成蛋白,已知抑制它可阻止无胸腺小鼠体内的人类肿瘤生长。它由肿瘤细胞和正常细胞分泌;并与内皮细胞和平滑肌细胞相互作用,诱导多种细胞反应,包括细胞迁移、侵袭、增殖以及管状结构的形成。血管生成素迅速被内吞并转运至细胞核,在核仁中积累并与DNA结合。尽管核转位对其血管生成活性是必需的,但血管生成素的核功能尚不清楚。在此我们报告,外源性血管生成素可增强内皮细胞中45S rRNA的产生,而内源性血管生成素的减少则会抑制其转录。在核转录分析中,血管生成素刺激RNA合成,包括含有45S rRNA起始位点序列的RNA合成。这表明血管生成素的核功能与其诱导rRNA合成的能力有关。由于rRNA转录对于蛋白质翻译和细胞生长所必需的新核糖体的合成至关重要,抑制血管生成素刺激的rRNA转录可能会抑制血管生成,因此可作为治疗干预的分子靶点。